Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM)

$0.25 USD

0.01 (-3.85%)

Updated Jun 25 8:04pm

Add ATNM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

ATNM Daily Price Range
ATNM 52-Week Price Range

ATNM News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All ATNM News

Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (ATNM) Company Bio

Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted payload immunotherapeutics for the treatment of advanced cancers. The company’s targeted radio immunotherapy products are based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting Actinium-225 and Bismuth-213, and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. The company was founded in 2000 and is based in New York City, New York.

ATNM Stock Chart More Charts

ATNM Price/Volume Stats

Current price $0.25
Prev. close $0.26
Day low $0.24
Day high $0.27
50-day MA $0.29
200-day MA $0.50
52-week high $0.87
52-week low $0.23
Volume 922,000
Avg. volume 1,216,426
Dividend yield N/A
Market Cap 40.51M

ATNM Social Stream

Loading social stream, please wait...

View Full ATNM Social Stream

ATNM Returns

1-mo -15.11%
3-mo -46.71%
6-mo -33.33%
1-year -59.02%
3-year -85.47%
5-year -96.46%
YTD -35.90%
2018 -40.91%
2017 -24.14%
2016 -73.07%
2015 -45.16%
2014 0.00%
Page generated in 0.444 seconds.